Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;168(1):92-110.
doi: 10.1093/rpd/ncv016. Epub 2015 Mar 31.

S values for 131I based on the ICRP adult voxel phantoms

Affiliations

S values for 131I based on the ICRP adult voxel phantoms

Stephanie Lamart et al. Radiat Prot Dosimetry. 2016 Jan.

Abstract

To improve the estimates of organ doses from nuclear medicine procedures using (131)I, the authors calculated a comprehensive set of (131)I S values, defined as absorbed doses in target tissues per unit of nuclear transition in source regions, for different source and target combinations. The authors used the latest reference adult male and female voxel phantoms published by the International Commission on Radiological Protection (ICRP Publication 110) and the (131)I photon and electron spectra from the ICRP Publication 107 to perform Monte Carlo radiation transport calculations using MCNPX2.7 to compute the S values. For each phantom, the authors simulated 55 source regions with an assumed uniform distribution of (131)I. They computed the S values for 42 target tissues directly, without calculating specific absorbed fractions. From these calculations, the authors derived a comprehensive set of S values for (131)I for 55 source regions and 42 target tissues in the ICRP male and female voxel phantoms. Compared with the stylised phantoms from Oak Ridge National Laboratory (ORNL) that consist of 22 source regions and 24 target regions, the new data set includes 1662 additional S values corresponding to additional combinations of source-target tissues that are not available in the stylised phantoms. In a comparison of S values derived from the ICRP and ORNL phantoms, the authors found that the S values to the radiosensitive tissues in the ICRP phantoms were 1.1 (median, female) and 1.3 (median, male) times greater than the values based on the ORNL phantoms. However, for several source-target pairs, the difference was up to 10-fold. The new set of S values can be applied prospectively or retrospectively to the calculation of radiation doses in adults internally exposed to (131)I, including nuclear medicine patients treated for thyroid cancer or hyperthyroidism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cross section of the geometric model used for the dosimetry simulation of walled organs (as described in the ICRP Publication 100), where tw is organ wall thickness; dt,in and dt,out are inner and outer depth limits of the target cell layers within the organ wall, respectively; and ds is the depth of the extent of the source region into the organ wall.
Figure 2.
Figure 2.
S values for 131I assumed to be uniformly distributed in the thyroid, urinary bladder contents, salivary glands and small intestine contents for the ICRP male and female phantoms to radiosensitive target tissues for which tissue weighting factors (included in the parentheses next to each target tissues with r indicating remainder tissues) are assigned in the ICRP Publication 103.
Figure 3.
Figure 3.
S values for the brain, small intestine wall, active marrow and esophagus in the ICRP male and female phantoms for 131I assumed to be uniformly distributed in major source regions.
Figure 4.
Figure 4.
Electron and photon S values [mGy (Bq s)−1] for selected walled organs in the ICRP phantoms.
Figure 5.
Figure 5.
Ratio of the S value from the ICRP phantoms to the values from the ORNL phantoms for selected source regions and for radiosensitive target tissues except for the remainder tissues. Medians of the ratios are indicated for each target tissue by gender (M = male, F = female).

Similar articles

Cited by

References

    1. Beierwaltes W. H., Rabbani R., Dmuchowski C., Lloyd R. V., Eyre P., Mallette S. An analysis of “ablation of thyroid remnants” with I-131 in 511 patients from 1947–1984: experience at University of Michigan. J. Nucl. Med. 25, 1287–1293 (1984). - PubMed
    1. Meier D. A., Brill D. R., Becker D. V., Clarke S. E. M., Silberstein E. B., Royal H. D., Balon H. R. Procedure guideline for therapy of thyroid disease with (131)iodine. J. Nucl. Med. 43, 856–861 (2002). - PubMed
    1. Ron E., et al. Cancer mortality following treatment for adult hyperthyroidism. J. Am. Med. Assoc. 280, 347–355 (1998). - PubMed
    1. Willegaignon J., Stabin M. G., Guimaraes M. I., Malvestiti L. F., Sapienza M. T., Maroni M., Sordi G. M. Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy. Health Phys. 91, 123–127 (2006). - PubMed
    1. Smith T., Edmonds C. J. Radiation dosimetry in the treatment of thyroid carcinoma by I-131. Radiat. Prot. Dosim. 5, 141–149 (1983).

Publication types

Substances